7 results on '"Manganiello, Vincent C."'
Search Results
2. β-cell PDE3B regulates Ca2+-stimulated exocytosis of insulin
- Author
-
Walz, Helena A., primary, Wierup, Nils, additional, Vikman, Jenny, additional, Manganiello, Vincent C., additional, Degerman, Eva, additional, Eliasson, Lena, additional, and Holst, Lena Stenson, additional
- Published
- 2007
- Full Text
- View/download PDF
3. Type III cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE 3 gene family)
- Author
-
Manganiello, Vincent C., primary, Taira, Masato, additional, Degerman, Eva, additional, and Belfrage, Per, additional
- Published
- 1995
- Full Text
- View/download PDF
4. Role of phosphodiesterase 2 in growth and invasion of human malignant melanoma cells.
- Author
-
Kenichi Hiramoto, Taku Murata, Kasumi Shimizu, Hiroshi Morita, Madoka Inui, Manganiello, Vincent C., Toshiro Tagawa, and Naoya Arai
- Subjects
- *
CANCER cell growth , *CYCLIC nucleotide phosphodiesterases , *CANCER invasiveness , *ENZYME regulation , *ENZYME inhibitors - Abstract
Cyclic nucleotide phosphodiesterases (PDEs) regulate the intracellular concentrations and effects of adenosine 3',5'-cyclic monophosphate (cAMP) and guanosine 3',5'-cyclic monophosphate (cGMP). The role of PDEs in malignant tumor cells is still uncertain. The role of PDEs, especially PDE2, in human malignant melanoma PMP cell line was examined in this study. In PMP cells, 8-bromo-cAMP, a cAMP analog, inhibited cell growth and invasion. However, 8-bromo-cGMP, a cGMP analog, had little or no effect. PDE2 and PDE4, but not PDE3, were expressed in PMP cells. Growth and invasion of PMP cells were inhibited by erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA), a specific PDE2 inhibitor, but not by rolipram, a specific PDE4 inhibitor. Moreover, cell growth and invasion were inhibited by transfection of small interfering RNAs (siRNAs) specific for PDE2A and a catalytically-dead mutant of PDE2A. After treating cells with EHNA or rolipram, intracellular cAMP concentrations were increased. Growth and invasion were stimulated by PKA14-22, a PKA inhibitor, and inhibited by N6-benzoyl-c AMP, a PKA specific cAMP analog, whereas 8-(4-chlorophenylthio)-2'-O-methyl-cAMP, an Epac specific cAMP analog, did not. Invasion, but not growth, was stimulated by A-kinase anchor protein (AKAP) St-Ht31 inhibitory peptide. Based on these results, PDE2 appears to play an important role in growth and invasion of the human malignant melanoma PMP cell line. Selectively suppressing PDE2 might possibly inhibit growth and invasion of other malignant tumor cell lines. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
5. Role of phosphodiesterase type 3A and 3B in regulating platelet and cardiac function using subtype-selective knockout mice
- Author
-
Sun, Bing, Li, Haiquan, Shakur, Yasmin, Hensley, James, Hockman, Steve, Kambayashi, Junichi, Manganiello, Vincent C., and Liu, Yongge
- Subjects
- *
RODENTS , *BLOOD platelets , *HEART beat , *COLLAGEN - Abstract
Abstract: Phosphodiesterase type 3 (PDE3) is an important regulator of cAMP-mediated responses within the cardiovascular system. PDE3 exists as two subtypes: PDE3A and PDE3B, with distinct cellular and subcellular locations. Due to the lack of subtype-specific pharmacological tools, the definitive role of each subtype in regulating cardiovascular function has not been determined. In this study, we investigated platelet and cardiac function, using PDE3A and PDE3B gene knockout (KO) mice. Platelet-rich-plasma was prepared from the blood of KO and age-matched wild-type (WT) mice. PGE1 (1 μg/mL) almost completely inhibited aggregation of platelets from WT, PDE3A KO and PDE3B KO mice. In platelets from WT mice, cilostamide (100 μM), a selective PDE3 inhibitor, blocked collagen- and ADP-induced aggregation. In contrast, cilostamide had no effect on aggregation of platelets from PDE3A KO mice. In PDE3B KO mice, inhibition of collagen- and ADP-induced platelet aggregation was similar to that in WT mice. The resting intra-platelet cAMP concentration in platelets from PDE3A KO mice was twice that in the WT platelets. After PGE1 (0.1 μg/mL) stimulation, intra-cellular cAMP concentration was increased significantly more in platelets from PDE3A KO mice compared to WT mice. In vivo, PDE3A KO mice were protected against collagen/epinephrine-induced pulmonary thrombosis and death, while no such protection was observed in PDE3B KO mice. The heart rate of PDE3A KO mice was significantly higher, compared with age-matched WT mice, while that of PDE3B KO mice was similar to WT. There was no difference in cardiac contractility between PDE3A or PDE3B KO mice. Heart rate and contractility were increased in a similar dose-dependent fashion by isoproterenol in both types of KO mice. Cilostamide increased heart rate and contractility in WT and PDE3B KO but not in PDE3A KO mice. Compared to WT and PDE3B KO mice, cyclic AMP-PDE activity in membrane fractions prepared from the hearts of PDE3A KO mice was lower and not inhibited by cilostamide. The data suggest that PDE3A is the main subtype of PDE3 expressed in platelets and cardiac ventricular myocytes, and is responsible for the functional changes caused by PDE3 inhibition. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
6. β-cell PDE3B regulates Ca2+-stimulated exocytosis of insulin
- Author
-
Walz, Helena A., Wierup, Nils, Vikman, Jenny, Manganiello, Vincent C., Degerman, Eva, Eliasson, Lena, and Holst, Lena Stenson
- Subjects
- *
INSULIN , *HORMONES , *HUMAN anatomy , *PANCREATIC secretions - Abstract
Abstract: cAMP signaling is important for the regulation of insulin secretion in pancreatic β-cells. The level of intracellular cAMP is controlled through its production by adenylyl cyclases and its breakdown by cyclic nucleotide phosphodiesterases (PDEs). We have previously shown that PDE3B is involved in the regulation of nutrient-stimulated insulin secretion. Here, aiming at getting deeper functional insights, we have examined the role of PDE3B in the two phases of insulin secretion as well as its localization in the β-cell. Depolarization-induced insulin secretion was assessed and in models where PDE3B was overexpressed [islets from transgenic RIP-PDE3B/7 mice and adenovirally (AdPDE3B) infected INS-1 (832/13) cells], the first phase of insulin secretion, occurring in response to stimulation with high K+ for 5 min, was significantly reduced (∼25% compared to controls). In contrast, in islets from PDE3B−/− mice the response to high K+ was increased. Further, stimulation of isolated β-cells from RIP-PDE3B/7 islets, using successive trains of voltage-clamped depolarizations, resulted in reduced Ca2+-triggered first phase exocytotic response as well as reduced granule mobilization-dependent second phase, compared to wild-type β-cells. Using sub-cellular fractionation, confocal microscopy and transmission electron microscopy of isolated mouse islets and INS-1 (832/13) cells, we show that endogenous and overexpressed PDE3B is localized to insulin granules and plasma membrane. We conclude that PDE3B, through hydrolysis of cAMP in pools regulated by Ca2+, plays a regulatory role in depolarization-induced insulin secretion and that the enzyme is associated with the exocytotic machinery in β-cells. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
7. Beta-cell PDE3B regulates Ca2+-stimulated exocytosis of insulin.
- Author
-
Walz HA, Wierup N, Vikman J, Manganiello VC, Degerman E, Eliasson L, and Holst LS
- Subjects
- Animals, Arginine pharmacology, Cell Membrane drug effects, Cyclic Nucleotide Phosphodiesterases, Type 3, Humans, Insulin Secretion, Insulin-Secreting Cells cytology, Insulin-Secreting Cells drug effects, Membrane Potentials drug effects, Mice, Potassium pharmacology, Protein Transport drug effects, Secretory Vesicles drug effects, Subcellular Fractions drug effects, Subcellular Fractions enzymology, 3',5'-Cyclic-AMP Phosphodiesterases metabolism, Calcium metabolism, Exocytosis drug effects, Insulin metabolism, Insulin-Secreting Cells enzymology
- Abstract
cAMP signaling is important for the regulation of insulin secretion in pancreatic beta-cells. The level of intracellular cAMP is controlled through its production by adenylyl cyclases and its breakdown by cyclic nucleotide phosphodiesterases (PDEs). We have previously shown that PDE3B is involved in the regulation of nutrient-stimulated insulin secretion. Here, aiming at getting deeper functional insights, we have examined the role of PDE3B in the two phases of insulin secretion as well as its localization in the beta-cell. Depolarization-induced insulin secretion was assessed and in models where PDE3B was overexpressed [islets from transgenic RIP-PDE3B/7 mice and adenovirally (AdPDE3B) infected INS-1 (832/13) cells], the first phase of insulin secretion, occurring in response to stimulation with high K(+) for 5 min, was significantly reduced ( approximately 25% compared to controls). In contrast, in islets from PDE3B(-/-) mice the response to high K(+) was increased. Further, stimulation of isolated beta-cells from RIP-PDE3B/7 islets, using successive trains of voltage-clamped depolarizations, resulted in reduced Ca(2+)-triggered first phase exocytotic response as well as reduced granule mobilization-dependent second phase, compared to wild-type beta-cells. Using sub-cellular fractionation, confocal microscopy and transmission electron microscopy of isolated mouse islets and INS-1 (832/13) cells, we show that endogenous and overexpressed PDE3B is localized to insulin granules and plasma membrane. We conclude that PDE3B, through hydrolysis of cAMP in pools regulated by Ca(2+), plays a regulatory role in depolarization-induced insulin secretion and that the enzyme is associated with the exocytotic machinery in beta-cells.
- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.